Get the Stockscreener App
3.84
2.04%
-0.08
After Hours:
3.84
Aquestive Therapeutics Inc stock is traded at $3.84, with a volume of 716.96K.
It is down -2.04% in the last 24 hours and up +16.01% over the past month.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
See More
Previous Close:
$3.92
Open:
$3.98
24h Volume:
716.96K
Relative Volume:
0.49
Market Cap:
$381.42M
Revenue:
$58.36M
Net Income/Loss:
$-25.72M
P/E Ratio:
-10.55
EPS:
-0.3641
Net Cash Flow:
$-24.91M
1W Performance:
-8.57%
1M Performance:
+16.01%
6M Performance:
+27.15%
1Y Performance:
+0.00%
1-Day Range:
$3.82
$4.01
1-Week Range:
$3.82
$4.23
52-Week Range:
$2.12
$5.80
Aquestive Therapeutics Inc Stock (AQST) Company Profile
Name
Aquestive Therapeutics Inc
Sector
Phone
908-941-1900
Address
30 TECHNOLOGY DRIVE, WARREN, NJ
Compare AQST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AQST
Aquestive Therapeutics Inc
|
3.84 | 389.37M | 58.36M | -25.72M | -24.91M | -0.3641 |
|
ZTS
Zoetis Inc
|
145.79 | 66.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 42.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.43 | 43.30B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.45 | 19.30B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
128.23 | 13.53B | 2.41B | 305.80M | 492.20M | 2.95 |
Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | Oppenheimer | Outperform |
| Dec-17-24 | Initiated | Cantor Fitzgerald | Overweight |
| May-10-24 | Initiated | Leerink Partners | Outperform |
| Apr-11-24 | Initiated | Piper Sandler | Overweight |
| Mar-28-24 | Initiated | Raymond James | Outperform |
| Apr-07-21 | Resumed | RBC Capital Mkts | Outperform |
| Apr-22-19 | Initiated | H.C. Wainwright | Buy |
| Jan-03-19 | Initiated | Lake Street | Buy |
| Aug-20-18 | Initiated | JMP Securities | Mkt Outperform |
| Aug-20-18 | Initiated | RBC Capital Mkts | Outperform |
View All
Aquestive Therapeutics Inc Stock (AQST) Latest News
Strategies to average down on Aquestive Therapeutics Inc.Stock Selection With High Accuracy Based on Models - metal.it
Published on: 2025-07-29 20:47:23 - beatles.ru
Published on: 2025-07-29 19:03:19 - beatles.ru
Aquestive's Anaphylm to be reviewed by Health Canada - MSN
Published on: 2025-07-29 10:12:06 - metal.it
Published on: 2025-07-29 04:40:45 - metal.it
Investors Hope for Bounce in Aquestive Therapeutics Inc. After SelloffTriple Digit Return Stock Predictions Released - metal.it
Published on: 2025-07-28 23:49:46 - metal.it
Is Aquestive Therapeutics Inc. a growth stock or a value stockSmart Portfolio Recommendation For Beginners - jammulinksnews.com
Why Aquestive Therapeutics Inc. stock attracts strong analyst attentionLow Risk Equity Screener With Results Shared - metal.it
What institutional investors are buying Aquestive Therapeutics Inc. stockBuild a winning investment strategy - jammulinksnews.com
What are the latest earnings results for Aquestive Therapeutics Inc.Rapid market gains - jammulinksnews.com
What makes Aquestive Therapeutics Inc. stock price move sharplyBreakout Stocks Tips For Beginners - jammulinksnews.com
How does Aquestive Therapeutics Inc. generate profit in a changing economyOutperformance with explosive growth - jammulinksnews.com
Should I hold or sell Aquestive Therapeutics Inc. stock in 2025Maximize gains with strategic stock entries - jammulinksnews.com
How Efficient Is Aquestive Therapeutics Inc. at Controlling Operating CostsBreakout Confirmation Tool - metal.it
What are the technical indicators suggesting about Aquestive Therapeutics Inc.Unprecedented profit potential - jammulinksnews.com
What is the dividend policy of Aquestive Therapeutics Inc. stockUnlock powerful portfolio optimization tools - jammulinksnews.com
How strong is Aquestive Therapeutics Inc. company’s balance sheetAccelerated investment success - jammulinksnews.com
Is Aquestive Therapeutics Inc. a good long term investmentExceptional stock performance - PrintWeekIndia
What drives Aquestive Therapeutics Inc. stock priceDynamic growth stocks - PrintWeekIndia
What analysts say about Aquestive Therapeutics Inc. stock outlookTremendous gains - jammulinksnews.com
Why Aquestive Therapeutics Inc. stock is on top investor watchlistsDynamic capital growth - jammulinksnews.com
Should I buy Aquestive Therapeutics Inc. stock before earningsRapidly growing investment returns - jammulinksnews.com
Aquestive Therapeutics Inc. Stock Analysis and ForecastBreakthrough investment results - PrintWeekIndia
What analysts say about Aquestive Therapeutics Inc. stockAccelerated profit realization - jammulinksnews.com
Aquestive Therapeutics Names Sherry Korczynski as Chief Commercial Officer - GlobeNewswire
Aquestive Therapeutics Inc Stock (AQST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):